Monoclonal anti-IgE antibody: a novel therapy for allergic airways disease
- 1 February 2002
- journal article
- review article
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 88 (2) , 152-161
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthmaJournal of Allergy and Clinical Immunology, 2001
- AsthmaNew England Journal of Medicine, 2001
- Elevation of total serum immunoglobulin E is associated with asthma in nonallergic individualsEuropean Respiratory Journal, 2000
- Specific immunotherapy with a standardized latex extract versus placebo in allergic healthcare workersJournal of Allergy and Clinical Immunology, 2000
- Prevalence of IgE to natural rubber latex in unselected blood donors and performance characteristics of AlaSTAT testingAnnals of Allergy, Asthma & Immunology, 2000
- How much asthma is really attributable to atopy?Thorax, 1999
- Disease Management of Atopic Dermatitis: a Practice ParameterAnnals of Allergy, Asthma & Immunology, 1997
- Characterization of Complex Formation by Humanized Anti-IgE Monoclonal Antibody and Monoclonal Human IgEBiochemistry, 1995
- Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials.Thorax, 1992
- Association of Asthma with Serum IgE Levels and Skin-Test Reactivity to AllergensNew England Journal of Medicine, 1989